Clinical Trial Update: Intense Treatment Regimen With Intravitreal Aflibercept Injection [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating an intense intravitreal aflibercept treatment regimen for neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Vitreous -Retina- Macula Consultants of New York | Conditions: Neovascular Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN